Anti-IL-10 antibodies conjugated with liposomes are used to target the antitumor immune effects of IL-10 in leukemia. By blocking the action of IL-10, this treatment approach helps to restore tumor-specific immune responses and enhance the body's ability to eliminate tumor cells. Preclinical studies have shown that this targeted technology has the potential to improve therapeutic efficacy and reduce systemic side effects. Overall, anti-IL-10 antibody-conjugated liposomes provide a new direction for improving treatment strategies in leukemia patients.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
PFBW-080 | Rat Anti-IL10 Recombinant Antibody (clone 9D7); Fab Fragment | Neut | Rat Fab |
HPAB-0022-YC-F(E) | Human Anti-IL10 Recombinant Antibody; Fab Fragment (HPAB-0022-YC-F(E)) | ELISA, Neut | Humanized Fab |
HPAB-0223CQ-F(E) | Mouse Anti-IL10 Recombinant Antibody (clone B-N10); Fab Fragment | ELISA, FC, Block | Mouse Fab |
HPAB-0344-WJ-F(E) | Human Anti-IL10 Recombinant Antibody (clone 12G8); Fab Fragment | ELISA | Humanized Fab |
HPAB-0345-WJ-F(E) | Human Anti-IL10 Recombinant Antibody (clone 11D8); Fab Fragment | ELISA | Humanized Fab |
There are currently no Customer reviews or questions for VS-1024-FY160. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.